Search research articles
Contact Us
Filters
Showing results (211-220 of 590) with videos related to
Page
of 59
Sort By:
Hepatology (Baltimore, Md.)
|
November 1, 1996
Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents
P Scaglioni, M Melegari, M Takahashi, et al.
ANS. Advances in Nursing Science
|
August 9, 2011
A lifelong journey of moving beyond wartime trauma for survivors from Hiroshima and Pearl Harbor
Patricia Liehr, Chie Nishimura, Mio Ito, et al.
Hepatology (Baltimore, Md.)
|
August 29, 2000
Expression and antitumor effects of TRAIL in human cholangiocarcinoma
S Tanaka, K Sugimachi, K Shirabe, et al.
International Journal of Medical Sciences
|
June 22, 2005
Hepatitis B Virus e Antigen Variants
Shuping Tong, Kyun-Hwan Kim, Charles Chante, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 1984
Serum alpha-fetoprotein levels in human disease: perspective from a highly specific monoclonal radioimmunoassay
D H Bellet, J R Wands, K J Isselbacher, et al.
Molecular Pharmacology
|
February 27, 2013
NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cells
Xiaoxu Zhou, Dan Li, Murray B Resnick, et al.
Translational Oncology
|
July 29, 2019
A Novel Drug, CC-122, Inhibits Tumor Growth in Hepatocellular Carcinoma through Downregulation of an Oncogenic TCF-4 Isoform
Yoshito Tomimaru, Arihiro Aihara, Jack R Wands, et al.
American Journal of Obstetrics and Gynecology
|
January 1, 1988
Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease
M Ozturk, R Berkowitz, D Goldstein, et al.
Cancer Gene Therapy
|
August 5, 2000
Rabbit cytochrome P450 4B1: A novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma
L Mohr, N G Rainov, U G Mohr, et al.
Forum on Immunopathological Diseases and Therapeutics
|
October 11, 2011
Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma
Evan J Walker, Stephen A Rosenberg, Jack R Wands, et al.
Page
of 59
Search research articles
Search
Showing results (211-220 of 590) with videos related to
Sort By:
Page
of 59
Hepatology (Baltimore, Md.)
|
November 1, 1996
Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents
P Scaglioni, M Melegari, M Takahashi, et al.
ANS. Advances in Nursing Science
|
August 9, 2011
A lifelong journey of moving beyond wartime trauma for survivors from Hiroshima and Pearl Harbor
Patricia Liehr, Chie Nishimura, Mio Ito, et al.
Hepatology (Baltimore, Md.)
|
August 29, 2000
Expression and antitumor effects of TRAIL in human cholangiocarcinoma
S Tanaka, K Sugimachi, K Shirabe, et al.
International Journal of Medical Sciences
|
June 22, 2005
Hepatitis B Virus e Antigen Variants
Shuping Tong, Kyun-Hwan Kim, Charles Chante, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 1984
Serum alpha-fetoprotein levels in human disease: perspective from a highly specific monoclonal radioimmunoassay
D H Bellet, J R Wands, K J Isselbacher, et al.
Molecular Pharmacology
|
February 27, 2013
NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cells
Xiaoxu Zhou, Dan Li, Murray B Resnick, et al.
Translational Oncology
|
July 29, 2019
A Novel Drug, CC-122, Inhibits Tumor Growth in Hepatocellular Carcinoma through Downregulation of an Oncogenic TCF-4 Isoform
Yoshito Tomimaru, Arihiro Aihara, Jack R Wands, et al.
American Journal of Obstetrics and Gynecology
|
January 1, 1988
Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease
M Ozturk, R Berkowitz, D Goldstein, et al.
Cancer Gene Therapy
|
August 5, 2000
Rabbit cytochrome P450 4B1: A novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma
L Mohr, N G Rainov, U G Mohr, et al.
Forum on Immunopathological Diseases and Therapeutics
|
October 11, 2011
Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma
Evan J Walker, Stephen A Rosenberg, Jack R Wands, et al.
Page
of 59